Vaccines Market Insight Report Examines the Size and Value of the Vaccine Market As It is Today
Posted on: Monday, 14 January 2008, 06:00 CST
Research and Markets (http://www.researchandmarkets.com/reports/c79362) has announced the addition of "Vaccines Market Insight: Products, Pipelines & Market Outlook" to their offering.
This report examines the latest developments in the vaccine industry with particular emphasis placed on the role of vaccines in the prevention and treatment of cancer. It includes an overview of the immune system, an outline of how immunisation works and an assessment of how different types of vaccine work with that system. The report looks in particular at the suitability of cancer as a target for the next generation of vaccines.
The report examines the size and value of the vaccine market as it is today. This includes a full discussion of the vaccines that have reached the marketplace, including the first cancer vaccines. The vaccine market is currently dominated by a handful of pharmaceutical companies and these are also discussed.
The vaccine industry faces numerous opportunities as its understanding of the immune system grows, increasing both the number of vaccines in development and the range of suitable indications to target. However, there are also serious challenges that must be overcome: developers and manufacturers face technical and commercial challenges.
The report includes a full discussion of the many vaccines currently in development, focusing on those for cancer and for other unmet needs. The report concludes with profiles of the pharmaceutical and biotechnology companies that are actively developing cancer vaccines, as well as the major players in the vaccine market as a whole.
The report provides:
an overview of the immune system - enables an understanding of how vaccines have worked in the past and how an increasing knowledge of how the immune system works is affecting the types of vaccine currently in development.
a discussion of the immunological aspects of cancer
a summary of the types of vaccines available
a discussion of the vaccines market - how important cancer vaccines are and an assessment of the size of the market
a complete guide to the current vaccines on the market - background on the indications targeted by these vaccines and the companies that develop them
study of the major players in the market
review of the technical and commercial challenges - how to overcome the difficulties associated with vaccination
full study of the vaccines in development
profiles of 40 companies actively involved in the development of cancer vaccines
Contents: Chapter 1 Introduction Chapter 2 The Vaccines Market Chapter 3 Challenges And Opportunities Chapter 4 Vaccines In Development Chapter 5 Company Profiles List of Tables List of Figures
For more information visit http://www.researchandmarkets.com/reports/c79362
Source: Informa Healthcare
Source: Business Wire
Related Articles
- MarketsandMarkets: Global H1N1 2009 Influenza Vaccine Market Worth US$ 7,028 Million By 2011
- GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
- Cancer Vaccine Research Is Coming To Fruition, With A Number Of Products Now In Phase III Trials And 15 Therapeutic Cancer Vaccines Realistically Expected To Launch By 2013
- The Hot Emerging Area Of Cancer Vaccines And Tumour Immunity
- Cancer Vaccines Are the Newest Weapon in the Battle Against Cancer
- Global Vaccine Market Projected to Reach US$ 21.05 Billion By 2010 From US$ 11.42 Billion in 2006
- Vaccine Market to Top $23B
- In the Therapeutic Vaccine Industry, Cancer Vaccines Accounted for 60.6% of Projects Being Developed
- The First Major Launch of a Cancer Vaccine, Designed to Prevent Human Papillomavirus and Therefore Cervical Cancer, is Expected in 2006
 |
 |
User Comments (0)
RSS Feeds